Lv11
20 积分 2026-04-07 加入
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
2小时前
已完结
Lenvatinib: A Review in Refractory Thyroid Cancer
3小时前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
3小时前
已完结
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
3小时前
已完结
Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics
28天前
已完结
Autoimmune thyroid disorders
1个月前
已完结
Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis
1个月前
已完结
Treg plasticity and human diseases
1个月前
已完结
Metabolic control of T cells in autoimmunity
1个月前
已完结
Lipids guide T cell antitumor immunity by shaping their metabolic and functional fitness
1个月前
已完结
皖公网安备34019202002308
